Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 20/20 | 0.49 |
| ▸ | SRPK2 | P78362 | 1/20 | 0.39 |
| ▸ | SRPK1 | Q96SB4 | 1/20 | 0.39 |
| ▸ | EML4 | Q9HC35 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20366507 | 0.83 | ALK (0.72) | ALKSRPK2SRPK1EML4 | |
| SCHEMBL897657 | 0.82 | ALK (0.50) | ALK | |
| SCHEMBL897145 | 0.82 | ALK (0.63) | ALK | |
| SCHEMBL17448483 | 0.81 | ALK (0.43) | ALKSRPK2SRPK1EML4 | |
| SCHEMBL897442 | 0.81 | ALK (0.53) | ALK | |
| SCHEMBL20004151 | 0.80 | ALK (0.51) | ALK | |
| SCHEMBL20004636 | 0.78 | ALK (0.70) | ALKSRPK2SRPK1EML4 | |
| SCHEMBL897691 | 0.76 | ALK (0.50) | ALK | |
| SCHEMBL22369318 | 0.74 | ALK (0.43) | ALKSRPK2SRPK1EML4 | |
| SCHEMBL27087629 | 0.73 | ALK (0.45) | ALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3613729-A1 | TETRACYCLIC COMPOUNDS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2020-02-26 | — | — | EP | disclosed |
| EP-3345903-B1 | TETRACYCLIC COMPOUNDS | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2019-10-09 | — | — | EP | disclosed |
| EP-3345903-A1 | TETRACYCLIC COMPOUNDS | Chugai Seiyaku Kabushiki Kaisha (JP) | 2018-07-11 | — | — | EP | disclosed |
| EP-2975024-B1 | TETRACYCLIC COMPOUNDS | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2018-03-28 | — | — | EP | disclosed |